Board Meeting11 Nov 2026, 05:41 pm
Orchid Pharma Board Meeting on Nov 14 to Approve Q2 FY27 Results
AI Summary
Orchid Pharma Ltd has announced that its Board of Directors will convene on November 14, 2026, to consider and approve the Unaudited Limited Reviewed Financial Results (Standalone & Consolidated) for the second quarter and half-year ended September 30, 2026. The trading window for the company's securities will remain closed from October 1, 2026, until 48 hours after the declaration of these financial results.
Key Highlights
- Board meeting scheduled for November 14, 2026.
- To approve Unaudited Financial Results for Q2 and H1 FY27.
- Trading window closure in effect from October 1, 2026.
- Closure extends 48 hours post-results announcement.
Price Impact
More from ORCHPHARMA